{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:16:55Z","timestamp":1787987815472,"version":"build-2784847793"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Direct"],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Liver transplant (LT) recipients with autoimmune liver disease (primary sclerosing cholangitis, primary biliary cholangitis, autoimmune hepatitis) are at increased risk of developing acute cellular rejection (ACR), and in many cases graft failure due to recurrent disease. We describe our experience with dual immunosuppression without steroid maintenance and analyze its effect on disease recurrence; ACR; patient and graft survivals; and complications, such as sepsis and de novo malignancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included 74 consecutive LT recipients (April 2006 to April 2013) with autoimmune liver disease (primary sclerosing cholangitis, 20; primary biliary cholangitis, 23; autoimmune hepatitis, 31) from a single transplant center. Immunosuppression protocol included rabbit antithymocyte globulin for induction and mycophenolate mofetil with tacrolimus or sirolimus\/everolimus indefinitely for maintenance.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall 1-, 3-, 5-, and 7-year patient survival was 95.9%, 90.4%, 82,2% and 74.9%, re\u2013graft-free survival was 93.2%, 86.3%, 79.9%, and 72.8%, respectively (median follow-up, 5.5 years). In a multivariate Cox regression analysis, sepsis during post-LT period (<jats:italic toggle=\"yes\">P<\/jats:italic>= 0.040; hazard ratio [HR], 2.52; 95% confidence interval [CI], 1.04-6.11), steroid use for ACR (<jats:italic toggle=\"yes\">P<\/jats:italic>= 0.037; HR, 2.60; 95% CI, 1.06-6.34), and younger age (&lt;40 years) at LT (<jats:italic toggle=\"yes\">P<\/jats:italic>= 0.038; HR, 2.53; 95% CI, 1.05-6.10) predicted graft survival, whereas steroid use for ACR was the only variable that was predictive of overall patient survival (<jats:italic toggle=\"yes\">P<\/jats:italic>= 0.004; HR, 4.10; 95% CI, 1.59-10.52). Overall, 34 biopsy-proven ACR was noted in 22 LT recipients (30%), 13 (17.5%) had disease recurrence, and 34 episodes of sepsis occurred in 19 patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Dual immunosuppression protocol in LT recipients with autoimmune liver disease without corticosteroid maintenance had acceptable rates of survival and ACR without predisposing patients to the adverse effects of long-term steroid therapy.<\/jats:p><\/jats:sec>","DOI":"10.1097\/txd.0000000000000693","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T22:38:43Z","timestamp":1498257523000},"page":"e178","source":"Crossref","is-referenced-by-count":22,"title":["Outcomes of Liver Transplant Recipients With Autoimmune Liver Disease Using Long-Term Dual Immunosuppression Regimen Without Corticosteroid"],"prefix":"10.1097","volume":"3","author":[{"given":"Sanjaya K.","family":"Satapathy","sequence":"first","affiliation":[{"name":"Methodist University Hospital Transplant Institute, University of Tennessee Health Sciences Center, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ollie D.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, University of Tennessee Health Sciences Center, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Vanatta","sequence":"additional","affiliation":[{"name":"Methodist University Hospital Transplant Institute, University of Tennessee Health Sciences Center, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Kamal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Tennessee Health Sciences Center, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish K.","family":"Kedia","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Memphis, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Jiang","sequence":"additional","affiliation":[{"name":"School of Public Health, University of Memphis, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satheesh P.","family":"Nair","sequence":"additional","affiliation":[{"name":"Methodist University Hospital Transplant Institute, University of Tennessee Health Sciences Center, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Eason","sequence":"additional","affiliation":[{"name":"Methodist University Hospital Transplant Institute, University of Tennessee Health Sciences Center, Memphis, TN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,7]]},"reference":[{"key":"bib1-20231002","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bpg.2011.09.008","article-title":"Liver transplantation in autoimmune liver diseases","volume":"25","year":"2011","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"bib2-20231002","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/jhep.2002.35339","article-title":"Autoimmunity after liver transplantation","volume":"36","year":"2002","journal-title":"Hepatology"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/lt.24323","article-title":"Longterm corticosteroid use after liver transplantation for autoimmune hepatitis is safe and associated with a lower incidence of recurrent disease","volume":"22","year":"2016","journal-title":"Liver Transpl"},{"key":"bib4-20231002","first-page":"Cd007606","article-title":"Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1432-2277.2011.01335.x","article-title":"Steroid sparing protocols following nonrenal transplants; the evidence is not there. A systematic review and meta-analysis","volume":"24","year":"2011","journal-title":"Transpl Int"},{"key":"bib6-20231002","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1097\/TP.0000000000000477","article-title":"Steroid-free liver transplantation using rabbit antithymocyte globulin induction in 500 consecutive patients","volume":"99","year":"2015","journal-title":"Transplantation"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/jlts.2003.50096","article-title":"Recurrent primary biliary cirrhosis","volume":"9","year":"2003","journal-title":"Liver Transpl"},{"key":"bib8-20231002","doi-asserted-by":"crossref","first-page":"488","DOI":"10.12659\/AOT.890753","article-title":"Primary biliary cirrhosis in the era of liver transplantation","volume":"19","year":"2014","journal-title":"Ann Transplant"},{"key":"bib9-20231002","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.510250328","article-title":"Banff schema for grading liver allograft rejection: an international consensus document","volume":"25","year":"1997","journal-title":"Hepatology"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/0895-4356(95)00510-2","article-title":"Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy","volume":"48","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"bib11-20231002","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/00031305.2012.703873","article-title":"A simulation based evaluation of the asymptotic power formulae for cox models in small sample cases","volume":"66","year":"2012","journal-title":"Am Stat"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/lt.20910","article-title":"Recurrence of autoimmune liver disease after liver transplantation: a systematic review","volume":"12","year":"2006","journal-title":"Liver Transpl"},{"key":"bib13-20231002","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/lt.21403","article-title":"Recurrence of primary sclerosing cholangitis: what do we learn from several transplant centers?","volume":"14","year":"2008","journal-title":"Liver Transpl"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/lt.21313","article-title":"Clinically recurrent primary sclerosing cholangitis following liver transplantation: a time course","volume":"14","year":"2008","journal-title":"Liver Transpl"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/lt.21679","article-title":"A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts","volume":"15","year":"2009","journal-title":"Liver Transpl"},{"key":"bib16-20231002","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/jlts.2001.25357","article-title":"Disease recurrence after living liver transplantation for primary biliary cirrhosis: a clinical and histological follow-up study","volume":"7","year":"2001","journal-title":"Liver Transpl"},{"key":"bib17-20231002","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/jlts.2003.50213","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation: histologic estimate of incidence and natural history","volume":"9","year":"2003","journal-title":"Liver Transpl"},{"key":"bib18-20231002","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1097\/01.TP.0000090867.83666.F7","article-title":"The changing clinical presentation of recurrent primary biliary cirrhosis after liver transplantation","volume":"76","year":"2003","journal-title":"Transplantation"},{"key":"bib19-20231002","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/lt.21796","article-title":"Risk factors for recurrence of autoimmune hepatitis after liver transplantation","volume":"15","year":"2009","journal-title":"Liver Transpl"},{"key":"bib20-20231002","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/lt.21525","article-title":"Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal","volume":"14","year":"2008","journal-title":"Liver Transpl"},{"key":"bib21-20231002","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.transproceed.2007.02.030","article-title":"Liver transplantation for autoimmune hepatitis: a single-center experience","volume":"39","year":"2007","journal-title":"Transplant Proc"},{"key":"bib22-20231002","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1440-1746.2012.07125.x","article-title":"Impact of pretransplant antinuclear antibody and antismooth muscle antibody titers on disease recurrence and graft survival following liver transplantation in autoimmune hepatitis patients","volume":"28","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"bib23-20231002","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/lt.21394","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","year":"2008","journal-title":"Liver Transpl"},{"key":"bib24-20231002","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/00007890-199811270-00006","article-title":"Recurrent primary sclerosing cholangitis after orthotopic liver transplantation: is chronic rejection part of the disease process?","volume":"66","year":"1998","journal-title":"Transplantation"},{"key":"bib25-20231002","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(02)11861-7","article-title":"Risk factors for recurrence of primary sclerosing cholangitis of liver allograft","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"bib26-20231002","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/j.humpath.2003.07.015","article-title":"Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study","volume":"34","year":"2003","journal-title":"Hum Pathol"},{"key":"bib27-20231002","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/lt.21260","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation","volume":"14","year":"2008","journal-title":"Liver Transpl"},{"key":"bib28-20231002","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/lt.20444","article-title":"Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors","volume":"11","year":"2005","journal-title":"Liver Transpl"},{"key":"bib29-20231002","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1053\/jlts.2003.50143","article-title":"Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation","volume":"9","year":"2003","journal-title":"Liver Transpl"},{"key":"bib30-20231002","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1007\/s10620-009-0773-9","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after living donor liver transplantation: a single center experience","volume":"54","year":"2009","journal-title":"Dig Dis Sci"},{"key":"bib31-20231002","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.3748\/wjg.14.3388","article-title":"Transplantation in autoimmune liver diseases","volume":"14","year":"2008","journal-title":"World J Gastroenterol"},{"key":"bib32-20231002","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/j.1600-6143.2006.01256.x","article-title":"No improvement in long-term liver transplant graft survival in the last decade: an analysis of the UNOS data","volume":"6","year":"2006","journal-title":"Am J Transplant"},{"key":"bib33-20231002","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation","volume":"7","year":"2001","journal-title":"Liver Transpl"},{"key":"bib34-20231002","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/jhep.2001.20894","article-title":"Transplantation for primary biliary cirrhosis: retrospective analysis of 400 patients in a single center","volume":"33","year":"2001","journal-title":"Hepatology"},{"key":"bib35-20231002","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0168-8278(05)80206-5","article-title":"Recurrence of primary biliary cirrhosis after liver transplantation following FK506-based immunosuppression","volume":"17","year":"1993","journal-title":"J Hepatol"},{"key":"bib36-20231002","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0168-8278(96)80001-8","article-title":"Recurrence of primary biliary cirrhosis in the liver allograft: the effect of immunosuppression","volume":"24","year":"1996","journal-title":"J Hepatol"},{"key":"bib37-20231002","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/jhep.2000.9077","article-title":"Liver transplantation for autoimmune hepatitis: a long-term pathologic study","volume":"32","year":"2000","journal-title":"Hepatology"},{"key":"bib38-20231002","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00007890-199201000-00027","article-title":"Disease recurrence and rejection following liver transplantation for autoimmune chronic active liver disease","volume":"53","year":"1992","journal-title":"Transplantation"},{"key":"bib39-20231002","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/jlts.2002.32981","article-title":"Incidence and recurrence of autoimmune\/alloimmune hepatitis in liver transplant recipients","volume":"8","year":"2002","journal-title":"Liver Transpl"},{"key":"bib40-20231002","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/jhep.2000.16666","article-title":"Liver transplantation for autoimmune hepatitis","volume":"32","year":"2000","journal-title":"Hepatology"},{"key":"bib41-20231002","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.clinre.2011.02.007","article-title":"Liver transplantation in PBC and PSC: indications and disease recurrence","volume":"35","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"bib42-20231002","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-0031-1272834","article-title":"De novo autoimmune hepatitis after liver transplantation","volume":"31","year":"2011","journal-title":"Semin Liver Dis"},{"key":"bib43-20231002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3748\/wjg.v18.i1.1","article-title":"Recurrence and rejection in liver transplantation for primary sclerosing cholangitis","volume":"18","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"1 Pt 2","key":"bib44-20231002","first-page":"1563","article-title":"A comparative study of patients undergoing liver transplantation for primary sclerosing cholangitis and primary biliary cirrhosis","volume":"23","year":"1991","journal-title":"Transplant Proc"},{"key":"bib45-20231002","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1155\/2010\/830291","article-title":"The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation\u2014a single-centre experience","volume":"24","year":"2010","journal-title":"Can J Gastroenterol"},{"key":"bib46-20231002","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/lt.22018","article-title":"Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry","volume":"16","year":"2010","journal-title":"Liver Transpl"},{"key":"bib47-20231002","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0041-1345(96)00223-0","article-title":"Liver transplantation for autoimmune hepatitis: a 12-year experience","volume":"29","year":"1997","journal-title":"Transplant Proc"},{"key":"bib48-20231002","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0041-1345(99)00227-4","article-title":"Liver transplantation for autoimmune hepatitis: rejection and recurrence","volume":"31","year":"1999","journal-title":"Transplant Proc"},{"key":"bib49-20231002","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1432-2277.2007.00628.x","article-title":"The impact of disease recurrence on graft survival following liver transplantation: a single centre experience","volume":"21","year":"2008","journal-title":"Transpl Int"},{"key":"bib50-20231002","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1572-0241.2004.04050.x","article-title":"Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC","volume":"99","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"bib51-20231002","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/jlts.2003.36392","article-title":"Liver transplantation for primary biliary cirrhosis: a long-term pathologic study","volume":"9","year":"2003","journal-title":"Liver Transpl"},{"key":"bib52-20231002","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","article-title":"Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients","volume":"20","year":"2006","journal-title":"Clin Transplant"},{"key":"bib53-20231002","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/lt.21124","article-title":"Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation","volume":"13","year":"2007","journal-title":"Liver Transpl"},{"key":"bib54-20231002","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.transproceed.2005.03.130","article-title":"Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival","volume":"37","year":"2005","journal-title":"Transplant Proc"},{"key":"bib55-20231002","first-page":"35","article-title":"Mayo risk score for primary biliary cirrhosis: a useful tool for the prediction of course after liver transplantation?","volume":"13","year":"2008","journal-title":"Ann Transplant"},{"key":"bib56-20231002","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1432-2277.2008.00729.x","article-title":"Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far?","volume":"22","year":"2009","journal-title":"Transpl Int"},{"key":"bib57-20231002","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1600-6143.2005.00801.x","article-title":"Rapamycin successfully treats post-transplant autoimmune hepatitis","volume":"5","year":"2005","journal-title":"Am J Transplant"},{"key":"bib58-20231002","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cgh.2011.10.028","article-title":"Autoimmune hepatitis after liver transplantation","volume":"10","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"bib59-20231002","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/00007890-199812270-00013","article-title":"Outcome of autoimmune hepatitis after liver transplantation","volume":"66","year":"1998","journal-title":"Transplantation"},{"key":"bib60-20231002","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/jlts.2002.33485","article-title":"Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance","volume":"8","year":"2002","journal-title":"Liver Transpl"},{"key":"bib61-20231002","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jaut.2015.08.017","article-title":"\u201cDe novo\u201d and \u201crecurrent\u201d autoimmune hepatitis after liver transplantation: a comprehensive review","volume":"66","year":"2016","journal-title":"J Autoimmun"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/01845228-201707000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:24:04Z","timestamp":1750379044000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01845228-201707000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":61,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000000693","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}